Company: EOI
Filing Date: 2025-05-22
Form Type: DEF 14A
Source: 0001076598-25-000130
Chunk: 2

Company: Eaton Vance Enhanced Equity Income Fund
Filing Date: 2025-05-22
Form: DEF 14A
Chunk 2
---
 |
| Secretary                         |

May 22, 2025

Boston, Massachusetts

<div align='center'>IMPORTANT</div>

Shareholders can help avoid the necessity and additional expense
to the Fund(s) of further solicitations by promptly returning the enclosed proxy. The enclosed addressed envelope requires no postage
if mailed in the United States and is intended for your convenience.

<div align='center'>Eaton Vance Enhanced Equity Income Fund

One Post Office Square

Boston, Massachusetts 02109

PROXY STATEMENT</div>

This proxy statement is furnished in connection with the solicitation
of proxies by the Board of Trustees of Eaton Vance Enhanced Equity Income Fund (the “Fund”). The proxies will be voted at
the Annual Meeting of Shareholders of the Fund and at any adjournments or postponements thereof (the “Annual Meeting”). The
Annual Meeting will be held on Wednesday, July 9, 2025 at 11:30 a.m. (Eastern Time) at the principal office of the Fund, One Post Office
Square, Boston, Massachusetts 02109, as discussed further herein. The Annual Meeting will be held for the purposes set forth in the accompanying
notice. This proxy statement and the enclosed proxy cards are first being sent or given to shareholders on or about May 22, 2025.

The Board of Trustees of the Fund (the “Board” or the “Board
of Trustees”) has fixed the close of business on April 29, 2025 as the record date for the determination of the shareholders entitled
to notice of and to vote at the Annual Meeting and any adjournments or postponements thereof. As of April 29, 2025, there were 40,848,690 common shares of beneficial interest, $0.01 par value per share (“Common Shares”), of the Fund outstanding. See “Proxy
Solicitation, Tabulation and Voting Requirements” below for additional information. To the knowledge of the Fund, as of April 29,
2025: (i) no shareholder owned 5% or more of the Fund’s outstanding Common Shares, and (ii) the Trustees and executive officers
of the Fund, individually and as a group, owned beneficially less than 1% of the outstanding Common Shares of the Fund.

Shareholders as of the close of business on the record date of April
29, 2025, are entitled to attend and vote at the Annual Meeting. All properly executed proxies received prior to the Annual Meeting will
be voted